GR890100669A - Μέ?οδος παρασκευής νέων αλογονιδίων 0-(3-αμινο-2-υδροξυπροπυλ)-υδροξιμικού οξέος. - Google Patents

Μέ?οδος παρασκευής νέων αλογονιδίων 0-(3-αμινο-2-υδροξυπροπυλ)-υδροξιμικού οξέος.

Info

Publication number
GR890100669A
GR890100669A GR890100669A GR890100669A GR890100669A GR 890100669 A GR890100669 A GR 890100669A GR 890100669 A GR890100669 A GR 890100669A GR 890100669 A GR890100669 A GR 890100669A GR 890100669 A GR890100669 A GR 890100669A
Authority
GR
Greece
Prior art keywords
novel
acid halides
hydroxypropyl
amino
preparing
Prior art date
Application number
GR890100669A
Other languages
English (en)
Other versions
GR1002253B (en
Inventor
Nagy Peter Literati
Bela Balazs
Maria Boross
Jenoe Szilbereky
Gizella Zsila
Lajos Abraham
Gyoergy Blasko
Bela Gachalyi
Attila Almasi
Gabor Nemeth
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of GR890100669A publication Critical patent/GR890100669A/el
Publication of GR1002253B publication Critical patent/GR1002253B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

Δίδονται μια μέθοδος δια την παρασκευήν νέων αλογονιδίων υδροξιμικού οξέος και φαρμακευτικαί συνθέσεις αι οποίαι περιέχουν τις ανωτέρω νέες ενώσεις ως δραστικόν συστατικόν προς χρήσιν δια την θεραπείαν της διαβητικής αγγεοπάθειας. (χημικές ενώσεις) ω
GR890100669A 1988-10-20 1989-10-19 Novel 0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same GR1002253B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU885405A HU207988B (en) 1988-10-20 1988-10-20 Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components

Publications (2)

Publication Number Publication Date
GR890100669A true GR890100669A (el) 1990-11-29
GR1002253B GR1002253B (en) 1996-04-23

Family

ID=10970243

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100669A GR1002253B (en) 1988-10-20 1989-10-19 Novel 0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same

Country Status (20)

Country Link
US (3) US5147879A (el)
EP (1) EP0417210B1 (el)
JP (1) JPH0819078B2 (el)
KR (1) KR0154117B1 (el)
AU (1) AU620460B2 (el)
CA (1) CA2000830C (el)
DE (1) DE68913737T2 (el)
DK (1) DK175584B1 (el)
ES (1) ES2020030A6 (el)
FI (1) FI93214C (el)
GR (1) GR1002253B (el)
HU (1) HU207988B (el)
IE (1) IE65113B1 (el)
IL (1) IL92000A (el)
NO (1) NO178148C (el)
PL (1) PL164547B1 (el)
PT (1) PT92041B (el)
RU (1) RU2093508C1 (el)
UA (1) UA34412C2 (el)
WO (1) WO1990004584A1 (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100372312B1 (ko) * 1994-05-06 2003-05-09 바이오렉스 쿠타토 에스 페레즈토 알티 신규의히드록시믹산유도체,그를포함한약제학적조성물및그의제조방법
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
US6884424B2 (en) 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
HUT78138A (hu) 1995-12-22 2000-09-28 BIOREX Kutató és Fejlesztő Rt Hidroximsavszármazékot tartalmazó készítmény a növénytermesztés elősegítésére és alkalmazása
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
US6458371B1 (en) 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
AU745987B2 (en) * 1995-12-22 2002-04-11 N-Gene Research Laboratories Inc. A cosmetic composition and a method for reducing the ageing processes of skin
DE19607960A1 (de) * 1996-03-01 1997-09-04 Hoechst Schering Agrevo Gmbh Verfahren zur Herstellung von Ketonoximether durch Boronsäurekupplung
GB9613339D0 (en) * 1996-06-26 1996-08-28 Kritzinger Ann C Limp bookbinding assembly technique for two books in one pass
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
HU220971B1 (hu) * 1997-04-03 2002-07-29 BIOREX Kutató és Fejlesztő Rt. Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
US6933104B1 (en) 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
HUP0001583A2 (hu) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
ATE386523T1 (de) * 2001-07-17 2008-03-15 N Gene Res Lab Inc Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
HUP0105205A2 (hu) * 2001-11-29 2003-08-28 BIOREX Kutató és Fejlesztő Rt. Metformint és egy hidroxilaminszármazékot tartalmazó, gyógyászati készítmény
ES2298438T3 (es) * 2001-12-21 2008-05-16 Rhodia Inc. Composiciones estables combinadas de tensioactivos cationicos y anionicos.
AU2003202104B8 (en) * 2002-01-11 2008-10-02 Cytrx Corporation Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) * 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US20080227813A1 (en) * 2006-09-26 2008-09-18 Jack Raymond Barber Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
US7763601B2 (en) * 2006-11-02 2010-07-27 N-Gene Research Laboratories, Inc. Prevention and treatment of obesity
BRPI0919867A2 (pt) 2008-11-18 2015-12-15 Santen Pharmaceutical Co Ltd agente terapeutico ou profilatico para uma doenca degenerativa coriorretiniana, e metodo profilatico ou terapeutico para uma doenca degenerativa coriorrentiniana
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
KR101995300B1 (ko) 2018-03-30 2019-10-17 주식회사 아세아텍 다목적 관리기용 작업기 탈부착장치
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
CN112174853B (zh) * 2020-11-03 2023-07-25 湖南经世新材料有限责任公司 一种氨解法制备（z）-n-羟基苯脒的方法
US20230416224A1 (en) 2020-11-19 2023-12-28 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof
WO2023053008A1 (en) * 2021-09-28 2023-04-06 Kempharm Denmark A/S Oximes and their use in treatment of gba-related diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362845A1 (fr) * 1976-08-27 1978-03-24 Chinoin Gyogyszer Es Vegyeszet Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362845A1 (fr) * 1976-08-27 1978-03-24 Chinoin Gyogyszer Es Vegyeszet Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
IE65113B1 (en) 1995-10-04
ES2020030A6 (es) 1991-07-16
IL92000A (en) 1994-06-24
US5147879A (en) 1992-09-15
GR1002253B (en) 1996-04-23
RU2093508C1 (ru) 1997-10-20
IE893364L (en) 1990-04-20
CA2000830A1 (en) 1990-04-20
PT92041B (pt) 1995-07-18
EP0417210A1 (en) 1991-03-20
DE68913737T2 (de) 1994-07-28
FI93214B (fi) 1994-11-30
DK175584B1 (da) 2004-12-13
AU620460B2 (en) 1992-02-20
EP0417210B1 (en) 1994-03-09
NO902703D0 (no) 1990-06-18
UA34412C2 (uk) 2001-03-15
DE68913737D1 (de) 1994-04-14
HU207988B (en) 1993-07-28
HUT54110A (en) 1991-01-28
FI903075A0 (fi) 1990-06-19
KR0154117B1 (ko) 1998-12-01
AU4418689A (en) 1990-05-14
NO902703L (no) 1990-06-18
PT92041A (pt) 1990-04-30
US5296606A (en) 1994-03-22
JPH0819078B2 (ja) 1996-02-28
NO178148B (no) 1995-10-23
DK149790A (da) 1990-06-19
NO178148C (no) 1996-01-31
IL92000A0 (en) 1990-07-12
PL164547B1 (pl) 1994-08-31
WO1990004584A1 (en) 1990-05-03
JPH03502931A (ja) 1991-07-04
KR900701741A (ko) 1990-12-04
FI93214C (fi) 1995-03-10
CA2000830C (en) 1997-09-16
US5328906A (en) 1994-07-12
DK149790D0 (da) 1990-06-19

Similar Documents

Publication Publication Date Title
GR890100669A (el) Μέ?οδος παρασκευής νέων αλογονιδίων 0-(3-αμινο-2-υδροξυπροπυλ)-υδροξιμικού οξέος.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
IL84766A0 (en) Phosphinic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL60676A (en) Lipophilic muramyl peptides substituted by phosphoric acid derivatives,their manufacture and pharmaceutical compositions containing them
DE2962619D1 (en) 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts thereof, processes for their preparation, and pharmaceutical compositions containing such compounds
NO176550C (no) Fremgangsmåte for fremstilling av stabile, pressede, farmasöytiske formuleringer inneholdende en forbindelse
HUT45021A (en) Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
AU4936890A (en) Medicament containing dihydrolipoic acid as active substance
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
IL95052A0 (en) Phosphonic acid derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
PH15697A (en) 2-acetoxymethyl-2-methyl-(5r)-penam-3a-carboxylic acid,base salts thereof and pharmaceutical compositions containing same
FR2448541A1 (fr) Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
JPS56138174A (en) Phenylpiperazine derivative of 1,3,4-oxadiazolylphenol, manufacture and medicine containing same
DK116386A (da) Polyprenylforbindelser, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
IT7967658A0 (it) 2 4 etil i pipera inil 4 fenilchinoline procedimento per la loro prepara ione e composizioni farmaceutiche contenenti tali composti
DE2960968D1 (en) Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use
EG12366A (en) Process for the preparation of the o,o-dimethyl-o-(2,2-dichlorovinyl)esters or the o,o-diethyl-o-(2,2-dichlorovinyl esters of thionophosphoric acid,and their used as insecticides
ZA793425B (en) Substituted 2-phenylamino-2-imidazolines and acid addition salts thereof,processes for their preparation,and pharmaceutical compositions containing these compounds
IL60039A (en) N,n'-diphenyl-2-carboxy-4(phenylthio)-butanoic acid hydrazides,their preparation and pharmaceutical compositions containing them
ZA793230B (en) Novel oxothia compounds,processes for their preparation,pharmaceutical preparations containing these compounds and their use as a medicinal active compound
ES8705888A1 (es) Procedimiento para preparar compuetos de imidazo-isoquino-leina y de imidazo-tienopiridina
ZA793541B (en) Substituted 2-phenylamino-imidazoline-(2)derivatives and their acid addition salts,processes for their preparation and pharmaceutical compositions containing these compounds

Legal Events

Date Code Title Description
MA Right expired